Monoclonal antibody
Patritumab Type Whole antibody Source Human Target HER3 ATC code CAS Number ChemSpider UNII KEGG
Patritumab (INN) is a human monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator.[1] [2]
^ World Health Organization (2011). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 106" (PDF) . WHO Drug Information . 25 (4). ^ Horinouchi H (December 2016). "The prospect of patritumab for treating non-small cell lung cancer". Expert Opinion on Biological Therapy . 16 (12): 1549–1555. doi:10.1080/14712598.2016.1249846. PMID 27744717. S2CID 4035336.
Last Update: 2023-04-09T01:44:02Z
Patritumab (INN) is a human monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator. It is in a phase 2 clinical trial...
Word Count : 160
Last Update: 2024-05-28T09:50:59Z
Patritumab deruxtecan (U3-1402/ MK-1022) is an experimental antibody–drug conjugate developed by Merck and Daiichi Sankyo to treat non-small-cell lung...
Word Count : 288
Last Update: 2024-03-26T14:33:03Z
treatment of breast cancer or gastric or gastroesophageal adenocarcinoma. Patritumab deruxtecan, an experimental antibody–drug conjugate to treat non-small-cell...
Word Count : 586
Last Update: 2024-05-03T13:59:37Z
2021. "Patritumab Deruxtecan – U3-1402 – HER3 ADC". ADC Review. Retrieved 17 December 2020. Seymour, Caroline (30 January 2021). "Patritumab Deruxtecan...
Word Count : 2326
Last Update: 2024-05-15T00:45:19Z
Neuregulins (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding...
Word Count : 13791
Last Update: 2024-06-24T14:30:09Z
Neuregulins (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding...
Word Count : 8666
Last Update: 2024-06-20T00:22:49Z
Neuregulins (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding...
Word Count : 5993
Last Update: 2024-04-30T04:01:08Z
Neuregulins (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding...
Word Count : 3935
Last Update: 2024-01-12T10:54:50Z
Neuregulins (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding...
Word Count : 1049
Last Update: 2024-06-26T04:10:41Z
Neuregulins (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding...
Word Count : 661
Last Update: 2024-03-11T06:45:46Z
Neuregulins (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding...
Word Count : 1692
Last Update: 2024-04-12T21:07:16Z
Neuregulins (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding...
Word Count : 2053
Last Update: 2024-06-21T23:30:01Z
Neuregulins (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding...
Word Count : 3413
Last Update: 2024-03-10T06:38:02Z
Neuregulins (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding...
Word Count : 1543
Last Update: 2024-06-22T19:12:44Z
Neuregulins (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding...
Word Count : 15741
Last Update: 2024-03-26T05:49:17Z
Neuregulins (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding...
Word Count : 1645
Last Update: 2024-05-12T22:45:17Z
Neuregulins (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding...
Word Count : 4735
Last Update: 2024-05-22T05:48:39Z
Neuregulins (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding...
Word Count : 3010
Last Update: 2024-06-13T05:58:30Z
Neuregulins (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding...
Word Count : 552
Last Update: 2024-04-07T05:47:37Z
Neuregulins (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding...
Word Count : 1489
Last Update: 2024-06-03T04:54:51Z
Neuregulins (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding...
Word Count : 3071
Last Update: 2022-06-16T04:46:03Z
Neuregulins (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding...
Word Count : 1081
Last Update: 2024-04-26T23:53:23Z
Neuregulins (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding...
Word Count : 2786
Last Update: 2024-06-10T13:37:55Z
Neuregulins (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding...
Word Count : 1787
Last Update: 2024-03-20T19:54:30Z
Neuregulins (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding...
Word Count : 2542
Last Update: 2024-06-13T05:35:45Z
Neuregulins (heregulins) (1, 2, 6 (neuroglycan C)) Antibodies: Duligotumab Patritumab Seribantumab ErbB4/HER4 Agonists: Betacellulin Epigen Heparin-binding...
Word Count : 6565
Global Information